Source-grounded facts extracted from Israel Acquisitions Corp's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Israel Acquisitions Corp amended Sixth BCA Amendment with Gadfin Ltd. and Gadfin Regev Holdings Ltd. (effective 2026-05-31).
“On May 31, 2026, the Company, Gadfin, and Gadfin Regev Holdings Ltd., a company domiciled in Israel, entered into a sixth amendment to the BCA (the “ Sixth BCA Amendment ”).”
Israel Acquisitions Corp amended Fifth BCA Amendment with Gadfin Ltd. and Gadfin Regev Holdings Ltd. (effective 2026-05-15).
“On May 15, 2026, the Company, Gadfin, and Gadfin Regev Holdings Ltd., a company domiciled in Israel entered into a fifth amendment to the BCA (the “ Fifth BCA Amendment ”).”
Israel Acquisitions Corp amended Fourth Amendment to Business Combination Agreement with Gadfin Ltd. valued at Revision of Section 7.1(d) to extend termination date to May 15, 2026 (effective 2026-04-15).
“On April 15, 2026, the Company, Gadfin, and Gadfin Regev Holdings Ltd., a company domiciled in Israel entered into a fourth amendment to the BCA (the “ Fourth BCA Amendment ”).”
Israel Acquisitions Corp amended Third Amendment to Business Combination Agreement with Gadfin Ltd., Gadfin Regev Holdings Ltd. valued at Amendment to extend termination date to April 15, 2026 (effective 2026-03-13).
“On March 13, 2026, the Company, Gadfin, and Gadfin Regev Holdings Ltd., a company domiciled in Israel entered into a third amendment to the BCA (the “ Third BCA Amendment ”).”
Israel Acquisitions Corp amended Second BCA Amendment with Gadfin Ltd. valued at Revised Section 7.1(d) extending termination date to March 16, 2026 and removing automatic extension (effective 2025-12-31).
“On December 31, 2025, the Company, Gadfin, and Gadfin Regev Holdings Ltd., a company domiciled in Israel (“ NewPubco ”) entered into a second amendment to the BCA (the “ Second BCA Amendment ”).”
Israel Acquisitions Corp amended Administrative Services Agreement Waiver with Israel Acquisitions Sponsor LLC valued at Waiver of $10,000/month until business combination or liquidation and $240,000 accrued fees (effective 2025-12-31).
“On December 31, 2025, the Parties entered into a waiver to the Agreement (the “ Waiver ”) whereby the Parties agreed to waive the administrative fees due under the Agreement.”
Israel Acquisitions Corp: Adopted Fifth Amended and Restated Memorandum and Articles of Association to extend business combination deadline up to January 18, 2027 (effective 2026-01-16).
“the Company amended the Company’s Fourth Amended and Restated Memorandum and Articles of Association on January 16, 2026, in its entirety, by adopting the Company’s Fifth Amended and Restated Memorandum and Articles of Association”
Israel Acquisitions Corp amended Trust Agreement Amendment with Equiniti Trust Company, LLC valued at Amendment to extend the business combination deadline from January 18, 2026 to January 18, 2027, all (effective 2026-01-16).
“As approved by the shareholders of Israel Acquisitions Corp (the “ Company ”), by special resolution, at an extraordinary general meeting of shareholders held on January 16, 2026 (the “ Meeting ”), on January 16, 2026, the Company entered into an amendment (the “ Trust Agreement Amendment ”) to the Investment Management Trust Agreement, dated as of January 12, 2023 and amended on January 8, 2024 by Amendment No. 1 and on January 6, 2025 by Amendment No. 2, with Equiniti Trust Company, LLC (f/k/a American Stock Transfer & Trust Company) (the “ Trustee ”).”
Israel Acquisitions Corp received a nasdaq delisting notice notice regarding other (rules 5830).
“January 13, 2026, the Nasdaq Stock Market LLC (“ Nasdaq ”) issued a press release (the “ Nasdaq Press Release ”) pursuant to Nasdaq Listing Rule 5830 and Rule 12d2-2 of the Securities Exchange Act of 1934 (“ Exchange Act ”), as amended, regarding the delisting of the securities of Israel Acquisitions Corp, a Cayman Islands exempted company (the “ Company ”). Pursuant to the Nasdaq Press Release, Nasdaq plans to delist the Company’s (i) Class A ordinary shares, par value $0.0001 per share (the “ Class A Ordinary Shares ”), (ii) units, each consisting of one Class A Ordinary Share and one redeem”
Israel Acquisitions Corp entered into Waiver to Administrative Services Agreement with Israel Acquisitions Sponsor LLC valued at waiver of administrative fees, including $10,000 per month and $240,000 accrued fees (effective 2025-12-31).
“Item 1.01. Entry into a Material Definitive Agreement. On January 12, 2023, Israel Acquisitions Corp, a Cayman Islands exempted company (the “ Company ”) entered into an Administrative Services Agreement (the “ Agreement ”), with Israel Acquisitions Sponsor LLC (the “ Sponsor ”, together with the Company, the “ Parties ”). On December 31, 2025, the Parties entered into a waiver to the Agreement (the “ Waiver ”) whereby the Parties agreed to waive the administrative fees due under the Agreement. Pursuant to the Waiver, the waived administrative fees include (i) the $10,000 per month owed to the Sponsor until the consummation by the Company of an initial business combination or the Company’s liquidation, and (ii) the $240,000 accrued fees to date. The foregoing description of the Waiver is only a summary and is qualified in its entirety by reference to the full text of the Waiver, which is attached hereto as Exhibit 10.1, and incorporated by reference herein.”
Israel Acquisitions Corp received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(A), 5810(c)(3)(C)).
“November 25, 2025, the Company received a delist determination letter from the Staff (the “ Nasdaq Notice ”) advising the Company that the Staff had determined that the Company had not satisfied the conditions set forth in the Staff’s MVLS Notice to regain compliance with the MVLS Requirement. Accordingly, the Staff indicated that unless the Company requests a hearing panel appeal of the delist determination by December 2, 2025, its securities would be delisted on December 4, 2025. In connection with the delisting and suspension, Nasdaq has advised that it will complete the delisting by filing”
Israel Acquisitions Corp received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).
“May 28, 2025, Israel Acquisitions Corp (the “Company”) received a deficiency letter (the “MVLS Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, based on the market value of listed securities for the previous 30 consecutive business days, the listing of the Company’s securities was not in compliance with Nasdaq Listing Rule 5450(b)(2)(A) to maintain a minimum market value of listed securities of at least $50 million (the “MVLS Requirement”). In accordance with Nasdaq rules, the Company has a period of 180 calendar days (or unt”
Israel Acquisitions Corp: Adopted Fourth Amended and Restated Memorandum and Articles of Association to extend the deadline to consummate an initial business combination up to twelve times, through January 18, 2026 (effective 2025-01-06).
“As approved by the Company’s shareholders at the Meeting on January 6, 2025, by special resolution, the Company amended the Company’s Third Amended and Restated Memorandum and Articles of Association on January 6, 2025, in its entirety, by adopting the Company’s Fourth Amended and Restated Memorandum and Articles of Association in the form set forth in Annex A to the definitive proxy statement filed with the Securities and Exchange Commission on December 23, 2024 (the “ Extension Amendment ”), reflecting the extension of the date by which the Company must consummate an initial business combination from the Termination Date up to twelve (12) times to January 18, 2026, with each Extension comprised of one month (i.e., for a period of time ending up to 36 months after the consummation of the Company’s initial public offering) for a total of twelve (12) months after the Termination Date (assuming an initial business combination has not occurred) (the “ Extension Amendment Proposal ”).”
Israel Acquisitions Corp amended Business Combination Agreement with Pomvom Ltd. (effective 2024-04-22).
“On April 22, 2024, the Company and Pomvom entered into an amendment (the “Amendment”) to the Business Combination Agreement.”
Israel Acquisitions Corp: Adopted Third Amended and Restated Memorandum and Articles of Association to extend the business combination deadline up to 12 months (effective 2024-01-08).
“the Company amended the Company’s Second Amended and Restated Memorandum and Articles of Association on January 8, 2024, in its entirety, by adopting the Company’s Third Amended and Restated Memorandum and Articles of Association”
Israel Acquisitions Corp shareholders approved Adjournment Proposal at the 2024-01-08 meeting.
“The Adjournment Proposal was approved by ordinary resolution of the Company’s shareholders, and received the following votes: FOR AGAINST ABSTAIN 15,036,259 445,301 0”
Israel Acquisitions Corp shareholders approved Trust Agreement Amendment Proposal at the 2024-01-08 meeting.
“The Trust Agreement Amendment Proposal was approved by special resolution of the Company’s shareholders, and received the following votes: FOR AGAINST ABSTAIN 15,036,259 445,301 0”
Israel Acquisitions Corp shareholders approved Extension Amendment Proposal at the 2024-01-08 meeting.
“The Extension Amendment Proposal was approved by special resolution of the Company’s shareholders, and received the following votes: FOR AGAINST ABSTAIN 15,036,259 445,301 0”
Israel Acquisitions Corp entered into Business Combination Agreement with Pomvom Ltd. valued at approximately $125,000,000 (effective 2024-01-02).
“On January 2, 2024, Israel Acquisitions Corp, a Cayman Islands exempted company (the “ Company ” or “ IAC ”) and Pomvom Ltd., a company organized under the laws of the State of Israel (the “ Pomvom ”) entered into a business combination agreement (the “ Agreement ”),”
Sharon Barzik Cohen was appointed as Director at Israel Acquisitions Corp.
“On January 12, 2023, in connection with the IPO, Izhar Shay, Candice Beaumont, Peter Cohen, Roy Zisapel and Daniel Recanati (together with Ziv Elul and Sharon Barzik Cohen, the “Directors”) were each appointed to the board of directors of the Company (the “Board”).”
Ziv Elul was appointed as Director at Israel Acquisitions Corp.
“On January 12, 2023, in connection with the IPO, Izhar Shay, Candice Beaumont, Peter Cohen, Roy Zisapel and Daniel Recanati (together with Ziv Elul and Sharon Barzik Cohen, the “Directors”) were each appointed to the board of directors of the Company (the “Board”).”
Daniel Recanati was appointed as Director at Israel Acquisitions Corp.
“On January 12, 2023, in connection with the IPO, Izhar Shay, Candice Beaumont, Peter Cohen, Roy Zisapel and Daniel Recanati (together with Ziv Elul and Sharon Barzik Cohen, the “Directors”) were each appointed to the board of directors of the Company (the “Board”).”
Roy Zisapel was appointed as Director at Israel Acquisitions Corp.
“On January 12, 2023, in connection with the IPO, Izhar Shay, Candice Beaumont, Peter Cohen, Roy Zisapel and Daniel Recanati (together with Ziv Elul and Sharon Barzik Cohen, the “Directors”) were each appointed to the board of directors of the Company (the “Board”).”
Peter Cohen was appointed as Director at Israel Acquisitions Corp.
“On January 12, 2023, in connection with the IPO, Izhar Shay, Candice Beaumont, Peter Cohen, Roy Zisapel and Daniel Recanati (together with Ziv Elul and Sharon Barzik Cohen, the “Directors”) were each appointed to the board of directors of the Company (the “Board”).”
Candice Beaumont was appointed as Director at Israel Acquisitions Corp.
“On January 12, 2023, in connection with the IPO, Izhar Shay, Candice Beaumont, Peter Cohen, Roy Zisapel and Daniel Recanati (together with Ziv Elul and Sharon Barzik Cohen, the “Directors”) were each appointed to the board of directors of the Company (the “Board”).”
Izhar Shay was appointed as Director at Israel Acquisitions Corp.
“On January 12, 2023, in connection with the IPO, Izhar Shay, Candice Beaumont, Peter Cohen, Roy Zisapel and Daniel Recanati (together with Ziv Elul and Sharon Barzik Cohen, the “Directors”) were each appointed to the board of directors of the Company (the “Board”).”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.